Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
11/2010
11/23/2010US7838029 non-effervescent, solid dosage form containing mirtazapine, which is used to form mirtazapine pharmaceutical tablets; dosage form contains mirtazapine, a hydrophilic component, and at least one lubricant; may also contain a salivating agent
11/18/2010US20100292466 Efficient Synthesis Of Galanthamine
11/18/2010US20100292215 11beta-hydroxysteroid dehydrogenase type 1 active compounds
11/18/2010US20100292213 Anti-Inflammatory Agents
11/18/2010US20100292157 Combination Treatments for Alzheimer's Disease and Similar Diseases
11/18/2010US20100291299 Strontium and barium precursors for use in chemical vapor deposition, atomic layer deposition and rapid vapor deposition
11/17/2010CN101889000A Dibenzoazepine and dibenzooxazepine TRPA1 agonists
11/17/2010CN101885705A Preparation method of carbonyl di-lactame
11/16/2010US7834177 Catalytic dehydrogenation with gaseous hydrogen of 11a,10b-dihydro-6H-dibenz/b,f/oxireno[d] azepine-6-carboxamide; anticonvulsant; chemical intermediate
11/11/2010US20100286125 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning
11/11/2010US20100282081 Absorbent liquid, and apparatus and method for removing c02 or h2s from gas with use of absorbent liquid
11/11/2010CA2761241A1 Tetracycline compounds
11/10/2010EP1748988B1 A process for the preparation of iminostilbene derivatives
11/10/2010CN101880386A Recovery method of hexanolactam in polyamide-6 continuous polymerization production process
11/09/2010CA2434937C Phenyl derivatives
11/04/2010WO2010125040A1 Method for preparing lactams
11/04/2010US20100279997 Analgesic that binds filamin a
11/04/2010US20100279996 Novel analgesic that binds filamin a
11/03/2010EP2246331A1 NR2B-selective NMDA-receptor antagonists
11/03/2010EP2010498B1 Synthesis of acylaminoalkenylene amides useful as substance p antagonists
11/03/2010CN101878201A Fused indane compound
11/02/2010US7825111 Substituted spiroheterocycles
11/02/2010US7825110 Substituted spiroheterocycles
10/2010
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010122134A1 Nr2b-selective nmda-receptor antagonists
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273773 Dibenzoazepine and dibenzooxazepine trpa1 agonists
10/28/2010US20100273772 Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)
10/27/2010CN101027306B Method of preparing poly(ADP-ribose) polymerases inhibitors
10/26/2010US7820813 Reacting racemic (+-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide with (2R,3R)-di-O,O'-substituted-tartaric acid anhydride; precipitation of less soluble diastereoisomeric 10-O-di-O,O'-substituted-tartrate half-ester; hydrolysis
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2396956C Polypharmacophoric agents
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010119274A1 Monomer, polymer, and method of making it
10/21/2010US20100267695 Fused indane compound
10/21/2010US20100267693 Orodispersible pharmaceutical composition of ivabradine
10/21/2010US20100266717 Chemical and biological agents for the control of molluscs
10/20/2010EP2241554A1 Process for the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
10/20/2010EP2241553A1 Process for the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
10/20/2010EP1569929B9 Compounds and methods for the treatment or prevention of flavivirus infections
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010CN1805939B Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
10/13/2010CN101857548A Two-aromatic amino terminated dianthracene compound, preparation method and application thereof
10/13/2010CN101475531B Method for preparing caprolactam by nitrosation reaction
10/13/2010CN101035765B Sulfonamide derivatives
10/12/2010CA2455526C Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
10/07/2010WO2010113179A2 A process for the purification of eslicarbazepine acetate
10/07/2010WO2010112942A1 Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
10/07/2010WO2010112705A1 Novel method for the synthesis of ivabradine and the addition salts thereof with a pharmaceutically acceptable acid
10/07/2010WO2010112704A1 Novel method for the synthesis of ivabradine and the addition salts thereof with a pharmaceutically acceptable acid
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010CA2756397A1 Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
10/06/2010CN101851205A New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/06/2010CN101851204A New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/06/2010CN101851203A Method for continuously preparing hexanolactam by using cyclohexanone-oxime Beckmann rearrangement reaction
10/05/2010US7807828 derivatives of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine for modulating sleep disorder; side effect reduction
10/05/2010US7807664 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative or salt thereof
09/2010
09/30/2010WO2010111116A1 Fluoroquinolone carboxylic acid molecular crystals
09/30/2010US20100249398 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
09/30/2010US20100249397 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
09/30/2010US20100249396 Benzazepinone compound
09/30/2010CA2756769A1 Fluoroquinolone carboxylic acid molecular crystals
09/29/2010EP1758867B1 Process for preparing oxcarbazepine
09/28/2010US7803786 Pharmaceutical co-crystal compositions and related methods of use
09/23/2010US20100240640 (THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists
09/22/2010EP2229364A2 Dibenzoazepine and dibenzooxazepine trpa1 agonists
09/22/2010CN101117327B Preparation method of aminocaprolactam
09/21/2010US7799773 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans
09/21/2010CA2521492C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
09/16/2010US20100234550 High shear oxidation of wax
09/16/2010US20100234454 Treatment of cnidaria intoxication
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP1578748B1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
09/15/2010CN101830850A Efficient preparation method of (1'S)-homophenylalanine carboxylic ester-benzoazepine-bis chiral compound
09/14/2010CA2549431C Optically active quaternary ammonium salt having axial asymmetry and process for producing .alpha.-amino acid and derivative thereof with the same
09/08/2010EP1841741B1 Piperidine derivatives as prodrugs of potassium channel inhibitors
09/07/2010US7790724 c-fms kinase inhibitors
09/07/2010CA2496721C New process for synthesizing derivatives of 1,3-dihydro-2h-3-benzazepin-2-one and its application to the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/01/2010EP2222669A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
09/01/2010EP1603651B1 Distillative method for separating hexamethylenediamine from a mixture comprising hexamethylenediamine, -aminocapronitrile and tetrahydroazepine
09/01/2010CN1939918B Production of midanping
09/01/2010CN101817783A Method for preparing tolvaptan intermediate
08/2010
08/26/2010WO2010096384A2 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands
08/26/2010US20100216774 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
08/26/2010US20100216772 Novel Phenantridine Analogues and Uses Thereof
08/26/2010US20100216763 Heteroaryl Amide Derivatives
08/25/2010EP2221296A1 Fused indane compound
08/25/2010EP2220030A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
08/25/2010EP2004610B1 Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation
08/25/2010CN101815704A Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
08/25/2010CN101250148B Method for preparing caprolactam by phase rearrangement of cyclohexanone oxime liquid
08/24/2010US7781425 Such as n-amidine substituted dibenz[c,e]azepines; synthesis; base catalysts for high yield nucleophilic type reactions
08/19/2010US20100210624 Aryloxy- and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
08/18/2010CN101805289A Omega-crystal form, preparation method and medicine composite of ivabradine hydrochloride
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010CA2473203C Orodispersible pharmaceutical composition comprising ivabradine
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 88